Description
GESIMAX GASTRIC
Formula:
Each tablet with enteric coating, of Modi Fi-Each Release:
Naproxeno (equivalent to 550 mg
of sodium naproxeno) ………………………………………. …………………… 500 mg.
Esomeprazole (equivalent to 22.21 mg
of ESOMEPRAZOL TRIEDRATO) ……………………………………… .20 mg.
Excipients c.s.p.
GESIMAX® Gastric is indicated in adults for the symptomatic treatment of osteoarthritis, rheumatoid arthritis and ankylosing spondylitis, in patients at risk of developing gastric and / or duodenal ulcers associated with non-steroidal medications (NSAIDs) in which non-fi lixture treatment with minor doses of Naproxeno or other NSAIDs. Naproxen reduces pain and in fl ammation, while esomeprazole reduces the amount of stomach acid.
BENEFITS
Taking GESIMAX® Gastric provides the following benefits to the patient:
- Comfortable dosage of every 12 hours, so it is comfortable for the patient.
- Powerful Action Antin Fl Amatoria and Analgesica.
- Fast start of pain relief and in fl penth, at 15 minutes after taking the dose.
- The GESIMAX® Gastric tablets come with modified release layer, so the active ingredient is released into duodenum.
- GESIMAX® Gastric reduces the risk of ulcers and proposal problems that appear in patients who need to take NSAIDs.
